← 홈

전체 프로그램

ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 545개
AntibodyBiologicSeagen Inc.Vedotin in CD30+ Hematologi…Phase 2

anti-CD30 mAb (SGN-30, SGN-30 (anti-CD30 mAb))

Anaplastic Large-Cell Lymphoma · CD30

#CD30#Antibody#Phase2#인기#항체+5
효능 ORR 93%임상시험 58상태 ACTIVE
ADCBiologicstaleAmerican Society of Clinical On…Phase 2

Dabrafenib plus Trametinib (Dabrafenib plus Trametinib)

Lymphoma, Non-Hodgkin; Multiple Myeloma · Lymphoma, Non-Hodgkin

#LymphomaNon-Hodgkin#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 100%임상시험 57상태 RECRUITING
ADCBiologicSeagen Inc.Vedotin for Relapsed or Ref…Phase 2

SGN-35 (SGN-35)

Disease, Hodgkin; Lymphoma, Large-Cell, Anaplastic · Disease, Hodgkin

#DiseaseHodgkin#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 93%임상시험 57상태 ACTIVE
ADCBiologicstaleSeagenvedotin-containing regimen …Phase 2

BV (BrentuximabVedotin, BrentuximabVedotin (BV))

Hodgkin Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 2%임상시험 56상태 ACTIVE
ADCBiologicstaleBeijing InnoCare Pharma Tech Co…Phase 3

Orelabrutinib (Orelabrutinib)

Primary Central Nervous System Lymphoma · Diffuse Large B Cell Lymphoma

#DiffuseLargeBCellLymphoma#ADC#Phase3#인기#항체약물접합체+3
임상시험 56상태 RECRUITING
CGTBiologicstaleKitevedotin plus bendamustine a…Approved

axicabtagene ciloleucel (Yescarta, axi-cel)

Large B-cell Lymphoma; Lymphoma, B-Cell · FRα

#FR#CGT#Approved#인기#세포유전치료+5
효능 ORR 92%임상시험 53상태 RECRUITING
CGTBiologicstaleHebei Senlang Biotechnology Inc…Preclinical

CD19+CD22 CAR-T (CD19+CD22 CAR-T)

Relapsed or Refractory B-cell Non-Hodgkin Lymphoma · CD19

#CD19#CGT#Preclinical#인기#세포유전치료+5
임상시험 53상태 ACTIVE
CGTBiologicstaleCRISPR Therapeutics AGPhase 2

CD19-directed CAR-T cells (CD19-directed CAR-T cells)

B-cell Non-Hodgkin Lymphoma · CD19

#CD19#CGT#Phase2#인기#세포유전치료+5
효능 ORR 25%임상시험 53상태 ACTIVE
CGTBiologicstaleMatthew FrankPhase 1

CD22 CAR (CD22 CAR)

B-ALL; B-cell Non Hodgkin Lymphoma · CD22

#CD22#CGT#Phase1#인기#세포유전치료+5
임상시험 53상태 ACTIVE
ADCBiologicstaleCelgeneVedotinPhase 1

Romidepsin (Romidepsin)

Breast Adenocarcinoma; Metastatic Breast Carcinoma · Cutaneous T-cell Lymphoma (CTCL)

#CutaneousT-cellLymphomaCTCL#ADC#Phase1#인기#항체약물접합체+5
효능 ORR 50%임상시험 53상태 ACTIVE
ADCBiologicstaleKing Abdullah International Med…Vedotin Plus AVD versus ABV…Phase 2

ABVD (ABVD)

Classical Hodgkin Lymphoma; Hodgkin Lymphoma (Category) · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 96%임상시험 52상태 ACTIVE
AntibodyRocheDM1 lossPhase 2

Bendamustine + Rituximab (Bendamustine + Rituximab)

Marginal Zone Lymphoma(MZL) · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Phase2#인기#항체+5
효능 ORR 95%임상시험 52상태 RECRUITING
ADCBiologicstaleSWOG Cancer Research NetworkVedotin, and BelinostatPhase 3

Pirtobrutinib (Pirtobrutinib)

Richter Syndrome; Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 66.4%임상시험 52상태 RECRUITING
ADCBiologicstaleRochevedotin, rituximab, cycloph…Phase 2

Polatuzumab (Polatuzumab)

Diffuse Large B Cell Lymphoma (DLBCL); High Grade B Cell Lymphoma · Lymphoma

#Lymphoma#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 100%임상시험 52상태 RECRUITING
ADCBiologicSWOG Cancer Research NetworkVedotin Plus AVD versus ABV…Phase 2

Velban (Vinblastine, Vinblastine (Velban))

Anaplastic Large Cell Lymphoma, ALK-Positive · Anaplastic Large Cell Lymphoma, ALK-Posi

#AnaplasticLargeCellLymphomaALK-P#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 96%임상시험 52상태 RECRUITING
ADCBiologicstaleSeagenvedotin-containing regimen …Phase 2

SGN-35 (brentuximab vedotin, brentuximab vedotin (SGN-35))

Hodgkin's Lymphoma · Hodgkin's Lymphoma

#HodgkinsLymphoma#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 89.5%임상시험 52상태 ACTIVE
AntibodystaleSeagenvedotin-containing regimen …Phase 2

Brentuximab (Brentuximab)

Diffuse Large B Cell Lymphoma; Mediastinal Large B-cell Lymphoma · Diffuse Large B Cell Lymphoma

#DiffuseLargeBCellLymphoma#Antibody#Phase2#인기#항체+5
효능 ORR 89.5%임상시험 51상태 DISCONTINUED
ADCBiologicstaleSeagenvedotin-containing regimen …Phase 2

Adcetris (Brentuximab vedotin, Brentuximab vedotin (Adcetris))

Anaplastic Large Cell Lymphoma, ALK-Positive · Anaplastic Large Cell Lymphoma, ALK-Posi

#AnaplasticLargeCellLymphomaALK-P#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 89.5%임상시험 51상태 RECRUITING
ADCBiologicSeagen Inc.Vedotin Plus AVD versus ABV…Phase 2

Adriamycin, vinblastine, and dacarbazine (Adriamycin, vinblastine, and dacarbazine)

Hodgkin Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 96%임상시험 50상태 ACTIVE
AntibodystaleGenmabPhase 2

Epcoritamab (Epcoritamab)

Diffuse Large B-Cell Lymphoma; Follicular Lymphoma · Non-Hodgkin Lymphoma

#Non-HodgkinLymphoma#Antibody#Phase2#인기#항체+5
효능 ORR 0%임상시험 50상태 RECRUITING

4 / 28 페이지

← 이전다음 →